University of Erlangen, Germany
Stephan Achenbach was the Founding President of the Society of Cardiovascular Computed Tomography. He is President Elect and Board Member of the European Society of Cardiology (ESC) and was Chairperson of the ESC Congress Programme Committee 2016-2018. As such, he was in charge of the ESC Congress 2017 in Barcelona and 2018 in Munich with approximately 30 000 attendees.
Stephan Achenbach has received several awards, including the Jan Brod Award for Clinical Research of the Medical School of Hannover, Germany (1999), the Thomas C. Cesario Distinguished Visiting Professorship Award, University of California Irvine School of Medicine (2007), the Simon Dack Award, American College of Cardiology (2009), the Gold Medal of the Society of Cardiovascular Computed Tomography (2015) and the Sir Godfrey Hounsfield Award of the British Institute of Radiology (2016). He was selected by AuntMinnie.com as the “Most Influential Radiology Researcher” in 2017, and he has repeatedly received the Best Teaching Award, Clinical Medicine, University of Erlangen-Nürnberg (2013, 2014, 2015, 2016, 2017, 2018).
Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Director, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Full Professor (Cardiology/Adult Congenital Heart Disease), University of Muenster, Germany
1993 – 2007 Staff cardiologist, Dept. of Cardiology, Medical University – Vienna General Hospital
1993 – 2007 Professor of Medicine / Cardiology, Medical University of Vienna
1993 – 2007 Director, Adult Congenital Heart Disease and Acquired Valvular Heart Disease Program, Medical University of Vienna
1993 – 2007 Director, Research Program on Adult Congenital Heart Disease and Acquired Valvular Heart Disease, Medical University of Vienna
1993 – 2007 Director, In-Vitro Echocardiography Research Laboratory
1993 – 2001 Director, Echocardiography Laboratory, Dept. of Cardiology, Medical University of Vienna
1992 – 1993 Staff cardiologist and Director, Echocardiography Laboratory, 2nd Department of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1981 – 1983 Internship, Krankenhaus der Barmherzigen Schwestern , Linz and St. Pölten General Hospital, Austria
1994 – 1989 Residency/Fellowship, Internal Medicine; 1st and 2nd Dept. of Internal Medicine, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1989 – 1990 Research Fellowship, Division of Cardiology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, USA
1990 – 1991 Clinical Fellowship in Cardiology; 2nd Dept. of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Clinical and basic research in the area of valvular heart disease and congenital heart disease
Clinical and experimental research in echocardiography
Catheter intervention in congenital and acquired valvular heart disease Myocardial viability
More than 250 publications, of these more than 150 papers in peer-reviewed journals
Medical Societies / Fellowships / Journals (selected)
Austrian Society of Cardiology: Chairman of the working group on adult congenital heart disease; President of the Society 2005-2007
European Society of Cardiology: Board member 2006-2008; Nucleus member of the working group on grown-up congenital heart disease, co-chairman 2004-2006, chairman 2006–2008, past-chairman 2008-2010, Chairman, TF Practice guidelines on the management of grown-up congenital heart disease, Task forces and committees (Practice guidelines on the management of valvular heart disease, Education committee, Accreditation committee), Clinical Practice Guidelines Committee (2010-2014),Congress Programme Committee (2010-2014)
A. John Camm
St. George’s University of London, UK
John Camm is Professor of Clinical Cardiology at St George’s Hospital Medical School, University of London, UK, and Imperial College, London.
Professor Camm’s interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, and risk stratification in post-myocardial infarction, heart failure and cardiomyopathy patients.
Professor Camm graduated from Guy’s Hospital, London and pursued a career in cardiology at St Bartholomew’s Hospital, London, before moving to St George’s in 1986. He was elected Chair of Medicine in October 1990. Professor Camm is a Fellow of the Royal College of Physicians (London, Edinburgh and Glasgow), The Academy of Medical Sciences, the American College of Cardiology, the American Heart Association, the Heart Rhythm Society, the European Society of Cardiology, the European Heart Rhythm Association. He is President of the Arrhythmia Alliance, Founder and Trustee of the Atrial Fibrillation Society, Trustee of the Drug Safety Research Unit, President of the European Heart Rhythm Society, Editor-in-Chief of European Heart Journal – Case Reports and Clinical Cardiology, Editor of the European Heart Journal, editorial board member of a further 15 journals, and Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine and ESC CardioMed.
Professor Camm has been involved in the production of numerous guidelines, including the ESC guidelines for the management of atrial fibrillation and the NICE guidelines for the treatment of unstable angina and non-ST elevation ACS. He has authored or co-authored over 1300 papers.
Professor Camm is a recipient of several honours including Queen’s Honorary Physician for his work in setting up and contributing to the medical protection of the Queen and the Royal Family over a period of 25 years, and Commander of the Venerable Order of St. John of Jerusalem for his contribution to teaching and service in the St. John Ambulance Brigade.
Professor Camm is the recipient of the European Society of Cardiology Gold Medal and the British Cardiovascular Society Mackenzie Medal.
Charles University Medical School I, Prague, Czech Republic
Department of Internal Medicine and Cardiology, Saarland University Hospital, Homburg, Germany
Dr Felix Mahfoud studied medicine at the Johann-Wolfgang-Goethe University, Frankfurt, Germany. He completed his residency at the Department of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany. He is currently associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital and Affiliate/Visiting Professor of the Harvard-MIT, Biomedical Engineering, Boston, MA. Dr Mahfoud has board certifications in internal medicine, cardiology, intensive care medicine, and hypertension. He is a recipient of multiple national and international awards. His special scientific interest includes pathophysiology, conservative and novel interventional therapies of hypertension and heart failure. He is member of several editorial boards and serves as board member of the European Society of Cardiology Council on Hypertension‚ Vice-Chair of the Working Group Interventional Hypertension Treatment of the European Society of Hypertension, EuroPCR Board of Directors, Co-Chairmen of the Resistant Hypertension Course, and program committee member of the ESC congress 2017 & 2018. Dr Mahfoud is involved as steering committee member in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.
Department of Anesthesiology and Critical Care Medicine, Hôpital Lariboisière, Paris, France
Bispebjerg Hospital, University of Copenhagen, Denmark
St George’s, University of London, St George’s Hospital NHS Trust, London, UK
University Hospital Zurich, Switzerland and University of Cape Town, South Africa
Friedrich Thienemann is an internal medicine and infectious diseases specialist with a strong clinical research background and a passion for global health. He is staff consultant at the Department of Internal Medicine of the University Hospital Zurich and Honorary Associated Professor at the Department of Medicine of the University of Cape Town and lives between Zurich and Cape Town.
After medical school at Charité University Hospital Berlin, Université Paris Descartes und University of Cape Town, Friedrich Thienemann undertook his post graduate training in internal medicine, infectious diseases, tropical medicine and global health at Charité University Hospital Berlin and University of Cape Town. Also received a Diploma in Tropical Medicine & Public Health and a MSc in International Health.
For the past ten years, the majority of his research work has been on the interaction of infectious disease and non-communicable disease, with special focus on HIV-associated cardiovascular disease. In 2009, he joined the Department of Medicine and the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town and served as investigator of several EU, NIH and university-funded grants and successfully administered multi-national, multi-site clinical research projects across Africa.
In 2019, Friedrich Thienemann established the research group General Medicine & Global Health (GMGH) with two sites, at the University of Zurich and at the Hatter Institute for Cardiovascular Research in Africa of the University of Cape Town. His current work is on optimizing diagnosis & treatment of tuberculosis, the intersection of infectious (tuberculosis and HIV) and non-communicable disease and the role of molecular imaging in infective lung disease.